Different SNPs in Fasciola hepatica P-glycoprotein from diverse Latin American populations are not associated with Triclabendazole resistance.
暂无分享,去创建一个
P. Smircich | J. Tort | S. Fernández | H. Solana | M. Domínguez | Santiago Radio | S. Scarcella | M. V. Solana
[1] Santiago Fontenla,et al. Pleiotropic alterations in gene expression in Latin American Fasciola hepatica isolates with different susceptibility to drugs , 2018, Parasites & Vectors.
[2] Juan C. Sánchez-DelBarrio,et al. DnaSP 6: DNA Sequence Polymorphism Analysis of Large Data Sets. , 2017, Molecular biology and evolution.
[3] K. Mehmood,et al. A review on epidemiology, global prevalence and economical losses of fasciolosis in ruminants. , 2017, Microbial pathogenesis.
[4] S. Paterson,et al. Fasciola hepatica demonstrates high levels of genetic diversity, a lack of population structure and high gene flow: possible implications for drug resistance , 2017, International journal for parasitology.
[5] Samantha N. McNulty,et al. Genomes of Fasciola hepatica from the Americas Reveal Colonization with Neorickettsia Endobacteria Related to the Agents of Potomac Horse and Human Sennetsu Fevers , 2017, PLoS genetics.
[6] J. Tort,et al. Fasciolosis in South America: epidemiology and control challenges , 2016, Journal of Helminthology.
[7] T. Beddoe,et al. Current Threat of Triclabendazole Resistance in Fasciola hepatica. , 2016, Trends in parasitology.
[8] T. Itagaki,et al. Molecular characterization and phylogenetic analysis of Fasciola hepatica from Peru. , 2016, Parasitology international.
[9] M. Nyindo,et al. Fascioliasis: An Ongoing Zoonotic Trematode Infection , 2015, BioMed research international.
[10] J. Dalton,et al. The Fasciola hepatica genome: gene duplication and polymorphism reveals adaptation to the host environment and the capacity for rapid evolution , 2015, Genome Biology.
[11] T. Spithill,et al. The T687G SNP in a P-glycoprotein gene of Fasciola hepatica is not associated with resistance to triclabendazole in two resistant Australian populations. , 2014, Molecular and biochemical parasitology.
[12] P. Ortiz,et al. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep. , 2013, Veterinary parasitology.
[13] I. Fairweather,et al. Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil , 2013, Parasitology.
[14] D. Williams,et al. Identification of putative markers of triclabendazole resistance by a genome-wide analysis of genetically recombinant Fasciola hepatica , 2013, Parasitology.
[15] C. Lanusse,et al. Identification of a field isolate of Fasciola hepatica resistant to albendazole and susceptible to triclabendazole. , 2013, Veterinary parasitology.
[16] C. Lanusse,et al. Testing albendazole resistance in Fasciola hepatica: validation of an egg hatch test with isolates from South America and the United Kingdom , 2013, Journal of Helminthology.
[17] I. Fairweather,et al. An amino acid substitution in Fasciola hepatica P-glycoprotein from triclabendazole-resistant and triclabendazole-susceptible populations. , 2012, Molecular and biochemical parasitology.
[18] V. Lovera,et al. Resistance of Fasciola hepatica against triclabendazole in cattle in Patagonia (Argentina). , 2011, Veterinary parasitology.
[19] G. Virkel,et al. Understanding triclabendazole resistance. , 2007, Experimental and molecular pathology.
[20] G. Virkel,et al. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes , 2005, Parasitology.